Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Peginterferon alfa-2a 180micrograms/0.5ml inj pf dispos dev
0802040A0AAANAN
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2a 180micrograms/0.5ml inj pfs
0802040A0AAAFAF
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2a 90micrograms/0.5ml inj pfs
0802040A0AAAPAP
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 100microgram inj pf dispos dev
0802040A0AAAKAK
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 100microgram inj vials
0802040A0AAABAB
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 120microgram inj pf dispos dev
0802040A0AAAIAI
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 120microgram inj vials
0802040A0AAAEAE
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 150microgram inj pf dispos dev
0802040A0AAAHAH
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 150microgram inj vials
0802040A0AAADAD
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 50microgram inj pf dispos dev
0802040A0AAAJAJ
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 50microgram inj vials
0802040A0AAACAC
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 80microgram inj pf dispos dev
0802040A0AAALAL
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 80microgram inj vials
0802040A0AAAAAA
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon beta-1a 125micrograms/0.5ml inj pf dispos dev
0802040APAAABAB
|
Peginterferon B | Peginterferon beta | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon beta-1a 63microg and 94microg/0.5ml inj
0802040APAAAAAA
|
Peginterferon B | Peginterferon beta | Malignant Disease and Immunosuppression | No data available |
|
PegIntron 100microgram inj vials
0802040A0BCABAB
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegintron 120microgram inj vials
0802040A0BCAEAE
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegintron 150microg inj vials
0802040A0BCADAD
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegintron 50microgram inj vials
0802040A0BCACAC
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegintron 80microgram inj vials
0802040A0BCAAAA
|
Pegintron | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pembrolizumab 100mg/4ml solution for infusion vials
0801050CAAAABAB
|
Pembrolizumab | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
|
Pembrolizumab 50mg powder for solution for infusion vials
0801050CAAAAAAA
|
Pembrolizumab | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
|
Pemetrexed 100mg powder for solution for infusion vials
0801030Y0AAABAB
|
Pemetrexed | Pemetrexed | Malignant Disease and Immunosuppression | No data available |
|
Pemetrexed 500mg powder for solution for infusion vials
0801030Y0AAAAAA
|
Pemetrexed | Pemetrexed | Malignant Disease and Immunosuppression | No data available |
|
Pentostatin 10mg powder for solution for injection vials
0801050S0AAAAAA
|
Pentostatin | Pentostatin | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.